ATE56096T1 - Test zur sofortigen feststellung von liganden, testsatz und seine herstellung. - Google Patents

Test zur sofortigen feststellung von liganden, testsatz und seine herstellung.

Info

Publication number
ATE56096T1
ATE56096T1 AT84301769T AT84301769T ATE56096T1 AT E56096 T1 ATE56096 T1 AT E56096T1 AT 84301769 T AT84301769 T AT 84301769T AT 84301769 T AT84301769 T AT 84301769T AT E56096 T1 ATE56096 T1 AT E56096T1
Authority
AT
Austria
Prior art keywords
reactant
beads
fluorescer
test
ligand
Prior art date
Application number
AT84301769T
Other languages
English (en)
Inventor
Jacques Henri Bertoglio-Matte
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE56096T1 publication Critical patent/ATE56096T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/534Production of labelled immunochemicals with radioactive label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Saccharide Compounds (AREA)
AT84301769T 1984-03-15 1984-03-15 Test zur sofortigen feststellung von liganden, testsatz und seine herstellung. ATE56096T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP84301769A EP0154734B1 (de) 1984-03-15 1984-03-15 Test zur sofortigen Feststellung von Liganden, Testsatz und seine Herstellung

Publications (1)

Publication Number Publication Date
ATE56096T1 true ATE56096T1 (de) 1990-09-15

Family

ID=8192592

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84301769T ATE56096T1 (de) 1984-03-15 1984-03-15 Test zur sofortigen feststellung von liganden, testsatz und seine herstellung.

Country Status (4)

Country Link
EP (1) EP0154734B1 (de)
JP (1) JPH0654313B2 (de)
AT (1) ATE56096T1 (de)
DE (1) DE3483099D1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868103A (en) * 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
GB8610426D0 (en) * 1986-04-29 1986-06-04 Leaback D H Bound assay components
US4943525A (en) * 1987-11-02 1990-07-24 Bioventures, Inc. Simultaneous immunoassay for the determination of antigens and antibodies
SE8804657D0 (sv) * 1988-12-27 1988-12-27 Gerald Potter Colin Support structure for use in a proximity assey
US6017496A (en) 1995-06-07 2000-01-25 Irori Matrices with memories and uses thereof
JP2000501171A (ja) * 1995-09-15 2000-02-02 メルク エンド カンパニー インコーポレーテッド 融合タンパク質を用いるハイスループットアッセイ
US6977141B2 (en) 1998-02-10 2005-12-20 Vicuron Pharmaceuticals Inc. Direct adsorption scintillation assay for measuring enzyme activity and assaying biochemical processes
EP1195604A1 (de) 2000-09-29 2002-04-10 Warner-Lambert Company Verfahren und Zusammensetzungen zum Screenen von Modulatoren von Lipidkinasen
SK142004A3 (en) 2001-06-11 2004-06-08 Applied Research Systems Scintillation proximity assays for aminoglycoside binding molecules
SE0104101D0 (sv) 2001-12-05 2001-12-05 Astrazeneca Ab New assay
SE0104102D0 (sv) 2001-12-05 2001-12-05 Astrazeneca Ab New assay
JP4845730B2 (ja) 2003-07-17 2011-12-28 プレキシコン,インコーポレーテッド Ppar活性化合物
US7348338B2 (en) 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
CN1925855B (zh) 2003-12-19 2010-06-16 普莱希科公司 开发Ret调节剂的化合物和方法
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
CA2565965A1 (en) 2004-05-06 2006-07-27 Plexxikon, Inc. Pde4b inhibitors and uses therefor
US7498342B2 (en) 2004-06-17 2009-03-03 Plexxikon, Inc. Compounds modulating c-kit activity
US7927820B2 (en) 2004-07-20 2011-04-19 Janssen Pharmaceutica Nv Assay systems and methods for detecting molecules that interact with membrane channels
EP1786813A2 (de) 2004-09-03 2007-05-23 Plexxikon, Inc. Bizyklische heteroaryl-pde4b-inhibitoren
AU2005311925A1 (en) 2004-11-30 2006-06-08 Plexxikon, Inc. Indole derivatives for use as PPAR PPAR active compounds
MX2007014377A (es) 2005-05-17 2008-02-06 Plexxikon Inc Inhibidores de proteina cinasa de derivados de pirrol (2,3-b) piridina.
PL2395004T3 (pl) 2005-06-22 2016-08-31 Plexxikon Inc Pochodne pirolo[2,3-b]pirydyny jako inhibitory kinazy białkowej
JP4652902B2 (ja) 2005-06-23 2011-03-16 株式会社日立ソリューションズ 安定保存された担体微小粒子
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
WO2008079909A1 (en) 2006-12-21 2008-07-03 Plexxikon, Inc. Pyrrolo [2,3-b] pyridines as kinase modulators
US7872018B2 (en) 2006-12-21 2011-01-18 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
PE20081581A1 (es) 2006-12-21 2008-11-12 Plexxikon Inc COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
PE20090159A1 (es) 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
MX2010000617A (es) 2007-07-17 2010-05-17 Plexxikon Inc Compuestos y metodos para modulacion de cinasa, e indicaciones de estos.
EA031116B1 (ru) 2009-04-03 2018-11-30 Ф. Хоффманн-Ля Рош Аг КРИСТАЛЛИЧЕСКИЕ ПОЛИМОРФНЫЕ ФОРМЫ {3-[5-(4-ХЛОРФЕНИЛ)-1H-ПИРРОЛО[2,3-b]ПИРИДИН-3-КАРБОНИЛ]-2,4-ДИФТОРФЕНИЛ}АМИДА ПРОПАН-1-СУЛЬФОНОВОЙ КИСЛОТЫ
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
UA105813C2 (uk) 2009-11-06 2014-06-25 Плексікон, Інк. Сполуки-інгібітори кіназ та фармацевтична композиція (варіанти)
PL2672967T3 (pl) 2011-02-07 2019-04-30 Plexxikon Inc Związki i sposoby modulacji kinaz i wskazania ku temu
TWI558702B (zh) 2011-02-21 2016-11-21 普雷辛肯公司 醫藥活性物質的固態形式
SG194847A1 (en) 2011-05-17 2013-12-30 Plexxikon Inc Kinase modulation and indications therefor
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
WO2016164641A1 (en) 2015-04-08 2016-10-13 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
US10829484B2 (en) 2015-07-28 2020-11-10 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
MX2018006856A (es) 2015-12-07 2018-08-01 Plexxikon Inc Compuestos y metodos para modulacion de la quinasa, e indicaciones de los mismos.
TW201815766A (zh) 2016-09-22 2018-05-01 美商普雷辛肯公司 用於ido及tdo調節之化合物及方法以及其適應症
WO2018136202A2 (en) 2016-12-23 2018-07-26 Plexxikon Inc. Compounds and methods for cdk8 modulation and indications therefor
US10428067B2 (en) 2017-06-07 2019-10-01 Plexxikon Inc. Compounds and methods for kinase modulation
CN113710668B (zh) 2019-04-09 2025-01-07 Opna生物公司 用于ep300或cbp调节及其适应症的缩合吖嗪
US12509444B2 (en) 2019-12-06 2025-12-30 Plexxikon Inc. Compounds and methods for CD73 modulation and indications therefor
US20210315869A1 (en) 2020-04-02 2021-10-14 Plexxikon Inc. Compounds and methods for csk modulation and indications therefor
AU2021261383A1 (en) 2020-04-23 2022-11-17 Opna Bio SA Compounds and methods for CD73 modulation and indications therefor
WO2022061251A1 (en) 2020-09-18 2022-03-24 Plexxikon Inc. Compounds and methods for kras modulation and indications therefor
WO2022240966A1 (en) 2021-05-11 2022-11-17 Opna Immuno-Oncology Sa Compounds and methods for yap/tead modulation and indications therefor
WO2024044570A1 (en) 2022-08-22 2024-02-29 Iambic Therapeutics, Inc. Compounds and methods for modulating her2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000252A (en) * 1974-01-04 1976-12-28 Kenneth Kosak Immunoscintillation cell
SE7811630L (sv) * 1977-11-17 1979-05-18 Welsh Nat School Med Metod for uppteckt eller mengdbestemning av substanser med anvendning av merkningsteknik
US4271139A (en) * 1978-03-27 1981-06-02 Hiram Hart Scintillation proximity assay
US4382074A (en) * 1978-03-27 1983-05-03 Hiram Hart Scintillation proximity assay
US4259313A (en) * 1978-10-18 1981-03-31 Eastman Kodak Company Fluorescent labels
CA1185177A (en) * 1981-07-17 1985-04-09 Larry E. Morrison Non-radiative energy transfer immunochemical technique

Also Published As

Publication number Publication date
DE3483099D1 (de) 1990-10-04
EP0154734B1 (de) 1990-08-29
JPH0654313B2 (ja) 1994-07-20
JPS60196668A (ja) 1985-10-05
EP0154734A1 (de) 1985-09-18

Similar Documents

Publication Publication Date Title
ATE56096T1 (de) Test zur sofortigen feststellung von liganden, testsatz und seine herstellung.
DK1042508T3 (da) Fremgangsmåder til forbedrede luminescensassays under anvendelse af mikropartikler
DE3175729D1 (en) Improved method and device for use with automated chemical analyses
ES8400199A1 (es) Procedimiento para la produccion de dispositivos de analisis inmunologicos.
JPS6447952A (en) Immunoassay, reagent used therefor and making thereof
EP0193895A3 (de) Lumineszierendes Testverfahren
TR199802020T2 (xx) Bir ��zeltiye reaktif ilavesinin hesaplanmas�nda kullan�lan �l��m d�zenlemesi.
FI875609A7 (fi) Testikantaja kehon nesteiden ainesosasten analyyttistä määritystä varten.
ATE239912T1 (de) Verfahren und vorrichtung zur referenzierung von fluoreszenzintensitätssignalen
DE3880531D1 (de) Integriertes immunoassayelement.
DE69022578D1 (de) Test für Hepatitis-C.
DE3856567D1 (de) Lumineszente Rhenium-Komplexe und Verfahren zur Herstellung
SE7704305L (sv) Forfarande for analys av ett biologiskt vetskeprov
FI831688L (fi) Test foer esterasaktivitet i ett flytande specimen
SE7706412L (sv) Sett och apparat for att signalera inforandet av kemiska reaktionskomponenter i ett kemiskt analyssytem
SE8803602D0 (sv) A sample plate with a plurality of sample wells or vials intended for radiolabeled binding assays
GB2002514A (en) Multilayer analytical elements
GB2008247A (en) Detecting or quantifying substances using labelling techniques
DE3584023D1 (de) Verfahren zur durchfuehrung von immunfluoreszenztesten.
GB1349491A (en) Fluorimetric assay of primary amino groups
ATE163764T1 (de) Testverfahren
JPS5714748A (en) Kit for quantitative determination of valproic acid and its method for quantitative determination
DE3485265D1 (de) Verfahren zur bestimmung eines polyvalenten antigens und reagenz hierfuer.
ES8601309A1 (es) Un metodo de medir un ligando biologico
JPS57149965A (en) Fluorescent immunoassay

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time